Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

المصدر: Nasdaq GlobeNewswire / 28 نوفمبر 2023 06:59:00   America/New_York